2025 Vaccine Adjuvants Industry Trends Report: Long-Term Outlook Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Vaccine Adjuvants Market Size By 2025?
In recent years, we saw a substantial expansion of the vaccine adjuvants market which is projected to increase from $1.89 billion in 2024 to $2.01 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.6%. The driving factors behind this historical growth can be traced back to heightened vaccine production, the proliferation of infectious diseases, government-led initiatives and immunization schemes, funding towards research and development, and the international dispersion of vaccine distribution.

How Big Is the Vaccine Adjuvants Market Size Expected to Grow by 2029?
In the forthcoming years, the vaccine adjuvants market is predicted to experience robust growth, escalating to a worth of $2.83 billion in 2029, with an 8.9% compound annual growth rate. The projected increase during this period can be attributed to factors such as pandemic readiness, the diversification of the vaccine catalogue, global vaccination goals, partnerships and alliances, and an emphasis on curative vaccines. Notable trends expected during this period include advancements in adjuvant technologies, focusing on improving immunogenicity, combining adjuvants for better effectiveness, the need for safer and better-tolerated adjuvants, and the personalization of vaccines and adjuvants.

View the full report here:
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Key Market Drivers Powering Vaccine Adjuvants Market Expansion and Growth?
The escalating occurrence of infectious diseases across the globe is predicted to fuel the expansion of the vaccine adjuvants market in the future. In infectious diseases, the causes can be bacteria, parasites, viruses, or fungi. Vaccines are implemented to manage these infections, which include diseases like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For example, the 2022 report by the World Health Organization (WHO) pointed out that around 10.6 million people worldwide had tuberculosis in 2021, with 1.6 million fatalities. Furthermore, in 2021, HIV affected 1.5 million people, and 650,000 of these individuals succumbed to the disease. Hence, the increasing incidence of infectious diseases is set to steer the growth of the vaccine adjuvants market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

What Trends Will Shape the Vaccine Adjuvants Market Through 2029 and Beyond?
A major trend steadily amassing traction in the vaccine adjuvants market is product innovation. Firms in the vaccine adjuvants industry are concentrating their efforts on implementing innovative strategies to bolster their standing in the market. In a pointed example from December 2022, Evonik Industries, a chemical manufacturer based in Germany, launched PhytoSquene, a squalene substitute derived from amaranth oil. This plant-based alternative to traditional squalene extracted from sharks is intended for use in vaccine adjuvants and other medicinal applications, increasing vaccine effectiveness by amplifying immune reactions. The creation of PhytoSquene signifies the rising focus on sustainability within the pharmaceutical industry.

What Are the Emerging Segments in the Vaccine Adjuvants Market?
The vaccine adjuvants market covered in this report is segmented -

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:
1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions
2) By Pathogen Components: Bacterial Components, Viral Components
3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles
4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems
5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Who Are the Global Leaders in the Vaccine Adjuvants Market?
Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Which are the Top Profitable Regional Markets for the Vaccine Adjuvants Industry?
North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.